Sphaira Medical raises 2.2 million euros

The Berlin start-up has developed a protective capsule designed to enable patients in medical isolation to have more contact with others. This convinces investors.

Medtech Sphaira Medical receives seed funding of 2.2 million euros. Investitionsbank Berlin Brandenburg (IBB) invests through its Early Stage and ProFIT programs. Business angels such as Caroll Neubauer, Florian Meißner and Silke Rickert-Sperling also participated in the financing round.

Since 2020, founder Janis Münch and his team have been working on the development of the Moby mobile protective capsule. The capsule enables vulnerable or infectious patients to have contact with relatives and medical staff. The start-up intends to use the new funding to drive forward clinical studies and the approval of the protective capsule, primarily in the EU and the USA.

"I hope that the fresh capital for Sphaira Medical will bring us a big step closer to the daily use of Moby for immunocompromised children with cancer and that we will be able to break through the stressful isolation of our patients more and more," says Angelika Eggert, Director of Pediatric Oncology at Charité Berlin.